Robert J Slack

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Cancer chemotherapy and pharmacology

International journal of molecular sciences

Nature communications

Galecto Biotech

University of Strathclyde (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Galecto Biotech Jan 07 2019

United Kingdom

Director of Pharmacology

GlaxoSmithKline Plc - Jan 04 2019

United Kingdom

Head of Translational Pharmacology :: Respiratory TAU

Education History

University of Strathclyde

United Kingdom

PHD :: Strathclyde Institute of Pharmacy & Biomedical Sciences

University of Bath

United Kingdom

MSC :: Pharmacy and Pharmacology

Publications

Henry Kim, Louis Kretz, Céline Ronin, Christina Starck, James A Roper, Barbro Kahl-Knutson, Kristoffer Peterson, Hakon Leffler, Ulf J Nilsson, Anders Pedersen, Fredrik R Zetterberg, Robert J Slack
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance. International journal of molecular sciences 25 (12) (2024)
Henry Kim, Louis Kretz, Céline Ronin, Christina Starck, James A Roper, Barbro Kahl-Knutson, Kristoffer Peterson, Hakon Leffler, Ulf J Nilsson, Anders Pedersen, Fredrik R Zetterberg, Robert J Slack
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance. International journal of molecular sciences 25 (12) (2024)
Henry Kim, Louis Kretz, Céline Ronin, Christina Starck, James A Roper, Barbro Kahl-Knutson, Kristoffer Peterson, Hakon Leffler, Ulf J Nilsson, Anders Pedersen, Fredrik R Zetterberg, Robert J Slack
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance. International journal of molecular sciences 25 (12) (2024)
Rhianna Gasson, James A Roper, Robert J Slack
A Quantitative Human Red Blood Cell Agglutination Assay for Characterisation of Galectin Inhibitors. International journal of molecular sciences 25 (12) (2024)
Rhianna Gasson, James A Roper, Robert J Slack
A Quantitative Human Red Blood Cell Agglutination Assay for Characterisation of Galectin Inhibitors. International journal of molecular sciences 25 (12) (2024)
Rhianna Gasson, James A Roper, Robert J Slack
A Quantitative Human Red Blood Cell Agglutination Assay for Characterisation of Galectin Inhibitors. International journal of molecular sciences 25 (12) (2024)
Vassilios Aslanis, Khalid Abd-Elaziz, Robert J Slack, Anne Brinch, Lise Gravelle, Wayne Morley, De Phung, Kimberly Herman, Ian Holyer, Karen Killerup Poulsen, Peter Dogterom, Susan Tantawi, Fredrik R Zetterberg, Brian Jacoby, Hans Schambye, Bertil Lindmark
Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1). Cancer chemotherapy and pharmacology (2024)
Vassilios Aslanis, Robert J Slack, Alison C MacKinnon, Catherine McClinton, Susan Tantawi, Lise Gravelle, Ulf J Nilsson, Hakon Leffler, Ashley Brooks, Sanjeev K Khindri, Richard P Marshall, Anders Pedersen, Hans Schambye, Fredrik Zetterberg
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants. Cancer chemotherapy and pharmacology 91 (3) (2023)
Vassilios Aslanis, Robert J Slack, Alison C MacKinnon, Catherine McClinton, Susan Tantawi, Lise Gravelle, Ulf J Nilsson, Hakon Leffler, Ashley Brooks, Sanjeev K Khindri, Richard P Marshall, Anders Pedersen, Hans Schambye, Fredrik Zetterberg
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants. Cancer chemotherapy and pharmacology 91 (3) (2023)
Vassilios Aslanis, Robert J Slack, Alison C MacKinnon, Catherine McClinton, Susan Tantawi, Lise Gravelle, Ulf J Nilsson, Hakon Leffler, Ashley Brooks, Sanjeev K Khindri, Richard P Marshall, Anders Pedersen, Hans Schambye, Fredrik Zetterberg
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants. Cancer chemotherapy and pharmacology 91 (3) (2023)
Vassilios Aslanis, Robert J Slack, Alison C MacKinnon, Catherine McClinton, Susan Tantawi, Lise Gravelle, Ulf J Nilsson, Hakon Leffler, Ashley Brooks, Sanjeev K Khindri, Richard P Marshall, Anders Pedersen, Hans Schambye, Fredrik Zetterberg
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants. Cancer chemotherapy and pharmacology (2023)
Vassilios Aslanis, Robert J Slack, Alison C MacKinnon, Catherine McClinton, Susan Tantawi, Lise Gravelle, Ulf J Nilsson, Hakon Leffler, Ashley Brooks, Sanjeev K Khindri, Richard P Marshall, Anders Pedersen, Hans Schambye, Fredrik Zetterberg
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants. Cancer chemotherapy and pharmacology (2023)
Vassilios Aslanis, Robert J Slack, Alison C MacKinnon, Catherine McClinton, Susan Tantawi, Lise Gravelle, Ulf J Nilsson, Hakon Leffler, Ashley Brooks, Sanjeev K Khindri, Richard P Marshall, Anders Pedersen, Hans Schambye, Fredrik Zetterberg
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants. Cancer chemotherapy and pharmacology 91 (3) (2023)
Alison E John, Rebecca H Graves, K Tao Pun, Giovanni Vitulli, Ellen J Forty, Paul F Mercer, Josie L Morrell, John W Barrett, Rebecca F Rogers, Maryam Hafeji, Lloyd I Bibby, Elaine Gower, Valerie S Morrison, Yim Man, James A Roper, Jeni C Luckett, Lee A Borthwick, Ben S Barksby, Rachel A Burgoyne, Rory Barnes, Joelle Le, David J Flint, Susan Pyne, Anthony Habgood, Louise A Organ, Chitra Joseph, Rochelle C Edwards-Pritchard, Toby M Maher, Andrew J Fisher, Natasja Stæhr Gudmann, Diana J Leeming, Rachel Clare Chambers, Pauline T Lukey, Richard P Marshall, Simon J F Macdonald, R Gisli Jenkins, Robert J Slack
Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis. Nature communications 11 (1) (2020)

Robert J Slack.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert J Slack